Previous 10 | Next 10 |
Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products focused on preventing opioid abuse, announced that its common stock and warrants...
ORLANDO, FL / ACCESSWIRE / October 4, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products focused on preventing opioid abuse, today announced...
ORLANDO, FL / ACCESSWIRE / October 1, 2021 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products focused on preventing opioid abuse, contract research and development services and the contract manufacturing of topical and transdermal p...
Nutriband Inc. Files Pro Forma Financials Consolidating the Recent Acquisition of Pocono Coated Products Transdermal and Topical Business and Active Intelligence PR Newswire ORLANDO, Fla. , Jan. 13, 2021 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada...
Nutriband (NTRB): Q3 GAAP EPS of -$0.01.Revenue of $391.8K (+374.5% Y/Y)Press Release For further details see: Nutriband reports Q3 results
Nutriband Inc. Records Record 375% Year-Over-Year Increase in Third Quarter Revenues and Record 69% Increase for Its Nine Month Revenues ORLANDO, Fla. , Dec. 16, 2020 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation, is pleased to announce that it has r...
Palm Beach, FL – December 15, 2020 – While the pharmaceutical industry has had an amazing record of developing therapeutic drugs for countless uses, sometimes, a remaining part of the problem is how do you get the drug into the patient’s body? The simplest way is usuall...
Nutriband Inc. Signs Exclusive License Agreement with RAMBAM Hospital Group for its Closed System Transfer Device ORLANDO, Fla. , Dec. 15, 2020 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation, announced that it signed an exclusive license agreemen...
Nutriband Inc. Receives Notice of Allowance from Korean Intellectual Property Office (KIPO) for its 'Abuse and Misuse Deterrent Transdermal System' Patent ORLANDO, Fla. , Dec. 10, 2020 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the "Comp...
Nutriband ( OTCQB:NTRB ) signs exclusive distribution agreement with Irish based Oran Textiles for Cifra reusable V-block coated facemasks. More news on: Nutriband Inc., Consumer stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Nutriband (NASDAQ: NTRB) , a pharmaceutical company with a special focus on transdermal technologies, is inviting investors to a live webinar. Scheduled for July 25, 2024, at 4:15 p.m. ET, this exclusive event will be hosted by RedChip Companies. During the webinar, Nutriband Chairman and Preside...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nutriband Cha...
Nutriband (NASDAQ: NTRB) , a developer of transdermal pharmaceutical products, has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”). According to the announcement, the notice means that the USPTO anticipates granting the trademark registrat...